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Astrocytes are highly secretory cells, participating in rapid brain communication by releasing glutamate. Recent evidences have
suggested that this process is largely mediated by Ca2+-dependent regulated exocytosis of VGLUT-positive vesicles. Here by
taking advantage of VGLUT1-pHluorin and TIRF illumination, we characterized mechanisms of glutamate exocytosis evoked
by endogenous transmitters (glutamate and ATP), which are known to stimulate Ca2+ elevations in astrocytes. At first we
characterized the VGLUT1-pHluorin expressing vesicles and found that VGLUT1-positive vesicles were a specific population of
small synaptic-like microvesicles containing glutamate but which do not express VGLUT2. Endogenous mediators evoked a burst
of exocytosis through activation of G-protein coupled receptors. Subsequent glutamate exocytosis was reduced by about 80% upon
pharmacological blockade of the prostaglandin-forming enzyme, cyclooxygenase. On the other hand, receptor stimulation was
accompanied by extracellular release of prostaglandin E
2
(PGE
2
). Interestingly, administration of exogenous PGE
2
produced per
se rapid, store-dependent burst exocytosis of glutamatergic vesicles in astrocytes. Finally, when PGE
2
-neutralizing antibody was
added to cell medium, transmitter-evoked exocytosis was again significantly reduced (by about 50%). Overall these data indicate
that cyclooxygenase products are responsible for a major component of glutamate exocytosis in astrocytes and that large part of
such component is sustained by autocrine/paracrine action of PGE
2
.
1. Introduction
The morphology and the location of astrocytes place them
in a unique position to be able to listen and respond to
neuronal activity [1–5]. Astrocytes express a wide variety of
functional neurotransmitter receptors essential for sensing
neuronal activity [6]. Many of these receptors are G-protein-
coupled receptors (GPCRs) that, upon activation, stimulate
phospholipase C and form inositol (1,4,5)-triphosphate (IP3)
which increases the intracellular calcium (Ca2+) concentra-
tion through the release of Ca2+ from intracellular stores [6].
The intracellular cascade resulting in Ca2+ rise in astrocytes
is the main mechanism these cells use to transduce synaptic
activity. It is well established that the GPCR- mediated Ca2+
variations in astrocytes can trigger release of chemical sub-
stances [7, 8] such as excitatory amino acids (D-serine, gluta-
mate) [2, 9, 10], ATP, and related nucleotides and nucleosides
[11–13] or proinflammatory mediators such as eicosanoids
(prostaglandins or PG) [2, 14] and tumor necrosis factor alpha
(TNF𝛼; [5, 15–17]). Interestingly, prostaglandin E
2
(PGE
2
)
and TNF𝛼 have been described to play an important role in
themodulation of the regulated secretion of glutamate [5, 15–
17]. PGE
2
and TNF𝛼 at pathological concentrations appear
to exert a potent control on Ca2+-dependent glutamate
release from astrocytes [15, 18] and therefore could directly
influence glial cells potentially resulting in complex changes
in the brain network. Thus, when a local inflammatory
reaction is triggered in the brain, the increased levels of such
proinflammatory mediators can deeply alter the properties
of glial network and thus of neuronal network [7]. However,
PGE
2
and TNF𝛼 are also present in the normal brain, albeit at
much lower levels than during inflammatory reactions. Con-
stitutive levels of TNF𝛼, in particular, have been implicated
in control of the stability of neuronal networks in response to
prolonged changes in activity via the phenomenonof synaptic
scaling [19, 20] and play a role in controlling the strength of
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excitatory synaptic transmission by promoting the insertion
of AMPA receptors at the surface [21, 22].The involvement of
TNF𝛼 in regulating glutamate release from astrocytes during
physiological conditions has been found in TNF𝛼- and TNF
receptor 1 knockout mice, pointing to a permissive role for
the cytokine in the exocytosis of glutamate from astrocytes
[17]. Recently, it has been discovered the way how TNF𝛼
modulates glutamate release from astrocytes and how this
impinges on the astrocytic modulation of synaptic activity
[5]. Much less information is available about the mechanism
by which PGs can control glutamate release in response to
activation of GPCRs [2, 15]. Here by taking advantage of a
construct containing the vesicular glutamate transporter 1
and a pH-sensitive fluorescent marker of fusion (VGLUT1-
pHluorin) and of total internal reflection fluorescence (TIRF)
microscopy, we investigated the role of PGs in the glutamate
exocytosis processes in astrocytes. We initially character-
ized secretory organelles expressing VGLUT1-pHluorin in
astrocytes and found that the VGLUT1-pHluorin-expressing
vesicles contain glutamate and belong to the family of
small synaptic-like microvesicles (SLMVs) and not of other
larger secretory organelles (such as dense core granules
or lysosomes). Then we found that the exocytosis of such
glutamatergic SLMVs, elicited by two endogenousmediators,
as diverse as glutamate and ATP, are strongly depressed by
pharmacological inhibition of cyclooxygenase (COX). We
also provide evidence that PGE
2
exerts most of its activity
in amplifying exocytosis of glutamate after it is released
in the extracellular medium. We conclude that activation
of COX pathway should be regarded as a crucial step in
the modulation of the GPCR mediated glutamate exocytosis
from astrocytes.
2. Material and Methods
2.1. Pharmacological Agents, Constructs, and Transfection.
All agents (acetylsalicylic acid, indomethacin, prostaglandin
E2, adenosine 5󸀠 triphosphate disodium salt (ATP), (+)-𝛼-
Methyl-4-carboxyphenylglycine (MCPG), adenosine-3󸀠-
phospho-5󸀠-phosphosulfate (A3P5PS), 2-methylthioadeno-
sine 5󸀠 diphosphate trisodium salt (2MeSADP), and (S)-3,5-
dihydroxyphenylglycine hydrate (DHPG)) were from Sigma
(St. Louis, USA), unless otherwise indicated. 2-Methyl-6-
(phenylethynyl)-pyridine (MPEP) and pyridoxalphosphate-
6-azophenyl-2󸀠,4󸀠-disulfonic acid tetrasodium salt (PPADS)
are from Tocris Cookson (Bristol, UK). Anti-PGE
2
antibody
(AbPGE
2
)was fromCaymanChemical (Liestal, Switzerland);
cyclopiazonic acid (CPA, CalBiochem, USA); Alexa 568-
conjugated transferrin (Life Technologies, USA); plasmid
containing the VGLUT1-pHluorin constructs was prepared
as previously described [24]. The plasmid (0.5 𝜇g for single
transfection experiments) was transfected into primary
rat cortical astrocytes cultures with FuGene6 (3 𝜇L, Roche
Diagnostics, Switzerland).
2.2. Astrocyte Cultures for Imaging Experiments. Astrocyte
cultures containing >99%GFAP-positive cells (≤8% of which
were positive for the neural precursor marker LeX) were
obtained fromnewborn rats.Theywere prepared as described
[9], plated (2.5 × 104 cells) on glass coverslip, and transfected
6–8-days later with VGLUT1-pHluorin. From 2 to 5 days
after transfection, and coverslips were mounted in the open
laminar flow perfusion incubator at 37∘C (Harvard Appara-
tus, USA) on the stage of a Zeiss Axiovert 200 fluorescence
inverted microscope modified for TIRF experiments (Vis-
itron System, Germany). The experimental chamber (250𝜇L
volume) was perfused at a rate of 1–1.5mL/min.The stimulus
(DHPG, ATP, tACPD/AMPA, PGE
2
, 2MeSADP) was applied
rapidly (2 sec) via a software-controlled microperfusion fast-
step device (100 𝜇L/min, Warner Instruments Corp., USA).
Cells were perfused at 37∘C in a HEPES-KRH buffer contain-
ing (in mM)NaCl 120, KCl 3.1, MgCl
2
2, CaCl
2
1.8, NaH
2
PO
4
1.25, HEPES-Na 25 (buffered to pH 7.4), and glucose 4.
In experiments with CPA, PPADS, A3P5PS, MCPG, MPEP,
INDO, ASA, and AbPGE
2
the drugs were diluted in HEPES-
KRH and incubated for 15min before the application of the
stimulus.
2.3. Optical Imaging. TIRF illumination (TIRFi) was used
for our experiments. The expanded beam of a 488/568 nm
argon/krypton multiline laser (20 milliwatts, Laserphysics,
Germany) passed through anAOTF laserwavelength selector
(VisiTech International, UK) synchronized with a SNAP-HQ
CCD camera (Roper Scientific, Germany) under Metafluor
software (Universal Imaging, USA) control and was intro-
duced to the coverslip from the high numerical aperture
objective lens (Zeiss 𝛼-plan FLUAR 100X). Light entered the
coverslip and underwent total internal reflection at the glass-
cell interface. In our experimental conditions, penetration
depth of TIRFi was calculated to be about 90 nm [17, 25].
In single-wavelength TIRFi experiments (488 nm) the laser
beam was filtered via the Zeiss filter set 10 and images
were acquired at 20–40Hz (Zeiss, Switzerland). In dual-
wavelength TIRF illumination (488/568 nm), laser beams
were combined by a dichroic mirror from the Zeiss filter 24
at 20–40Hz. The pixel size was 126 nm (at binning 2).
2.4. Image Analysis. Video images, digitized with MetaFluor,
were analyzed with MetaMorph software (Universal Imag-
ing, USA). The fusion events of VGLUT-pHluorin positive
vesicles were manually selected and counted in areas of
6000 pixels on cell surface as already reported [9, 26, 27].
A fluorescent spot was counted as “fusion event” when the
pHluorin fluorescence signal of a single SLMV increased over
basal by ≥4-fold.
2.5. Immunocytochemistry. Astrocytes were plated on glass
coverslips coated with 2mg/mL poly-L-lysine and 33mg/mL
laminin and cultured for 2 days. The cells were rinsed
with phosphate-buffered saline (PBS) and fixed in ice-cold
methanol for 15min. After two washes in ice-cold PBS, the
coverslips were incubated for 10min with PBS containing
0.5% saponin (PBS-S) and rinsed three times for 5min
with PBS. They were then incubated for 30min in PBS-
S containing 1% bovine serum albumin (BSA) and for 1
hour at room temperature in the presence of the primary
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antibodies diluted in PBS-S plus 1% BSA. The cells were
rinsed with PBS, incubated 1 hour with the secondary
antibody, and mounted for confocal microscopy (Leica
SP5 AOBS Confocal Microscope). Primary antibodies were
rabbit GFP (1 : 500, Chemicon), mouse VGLUT1 (1 : 500,
Chemicon), VGLUT2 (1 : 2000, gift Robert Edwards, USA),
VAMP3, (1 : 1000, Synaptic System), glutamate (1 : 3000, gift
Vidar Gundersen, Oslo), VAMP2 (1 : 1000, Synaptic System),
phogrin (1: 500, gift Romano Regazzi, Lausanne), LAMP1
(1 : 100, Calbiochem), EAA1 (1 : 100, BD Transduction Lab),
and Tf receptor (1 : 100, Invitrogen). Secondary antibodies
were Cy3 or FITC-conjugated (1 : 200, Molecular Probes).
2.6. Monitoring of Extracellular PGE
2
Formation. Extracellu-
lar PGE
2
was measured using a sensitive EIA kit (Prostagl-
andin E2 EIA kit-Monoclonal, Cayman Chemical Company,
Ann Arbor). Cultured astrocytes plated on Petri dishes
were washed twice with a KRH buffer containing (in mM)
NaCl 120, KCl 3.1, MgCl
2
2, CaCl
2
1.8, NaH
2
PO
4
1.25, and
HEPES-Na 25 (buffered to pH 7.4). Subsequently they were
stimulated (3min) with agents dissolved in the same buffer
also containing an antiPGE
2
antibody (AbPGE
2
, Cayman
Chemical) at concentration buffering >1000 pg/mL PGE
2
. At
the end of stimulations, the extracellular mediumwas rapidly
collected, lyophilized and kept at −80∘C until performing the
EIA assay according to instructions.
2.7. Statistical Analysis. Theexperiments were analyzed using
the SAS statistical package (SAS Inc., Cary, NC, USA). Statis-
tical differences were tested by t-test and 𝑃 values of 0.01∗∗ or
0.05∗.
3. Results
Glutamatergic vesicles in astrocytes have been highlighted
by transfecting cultured cells with the fluorescent construct
VGLUT1-pHluorin, consisting of vesicular glutamate trans-
porter 1 (VGLUT1) fused to a pH sensitive GFP mutant
(pHluorin; [28]). Overexpression of VGLUT1-pHluorin in
primary cortical astrocytes produced a punctate pattern of
fluorescence (Figure 1). Astrocytes, similar to specialized
secretory cells, contain three types of secretory organelles, the
glutamate containing synaptic-like microvesicles (SLMVs)
[9, 29, 30], the peptide containing large dense-core gran-
ules (LDCGs; [31, 32]), and the lysosomes [11–13]. These
secretory organelles can be distinguished by immunocyto-
chemistry and confocal analysis in primary cultured cells
by using antibodies directed against endogenous markers
[33]. In order to characterize which population of secre-
tory organelles expressed VGLUT1-pHluorin, we performed
a series of immunolabeling and confocal analysis. The
VGLUT1-expressing vesicles were well colocalized with anti-
VGLUT1 antibody (92 ± 3.5% for 𝑛 = 7 cells, Figure 1(a)) but
not with anti-VGLUT2 antibody (5 ± 2.7% for 𝑛 = 5 cells,
Figure 1(b)), indicating that VGLUT1-pHluorin is expressed
on a particular set of intracellular glutamatergic vesicles. The
VGLUT1-expressing vesicles showed a large co-localization
with markers of SLMVs [9] such as VAMP3 (or cellubrevin,
94±5.5%for 𝑛 = 5 cells, Figure 1(c)) and glutamate (92 ± 6.2%
for 𝑛 = 5 cells, Figure 1(d)). Interestingly, the VGLUT1-
associated vesicles showed only a small co-localization with
endogenous VAMP2 (17±2% for 𝑛 = 5 cells, Figure 1(e)) and
with markers of other secretory organelles such as LDCGs
(phogrin, 2.3±1.7% for 𝑛 = 5 cells, Figure 1(f)) or lysosomes,
(LAMP1, 3 ± 1.2% for 𝑛 = 5 cells, Figure 1(g)). We also
checked the co-localization of VGLUT1-positive vesicles with
other lysosomal markers, including early endosomes with
EAA1 (13 ± 7.3% for 𝑛 = 5 cells, Figure 1(h)) [34] and the
recycling endosomes with transferrin receptor (18 ± 7% for
𝑛 = 5 cells, Figure 1(i), [35]). Early endosomes and recycling
endosomes represent two distinct populations of endosomes
that significantly colocalized with VGLUT1-pHluorin (co-
localization about 20%). In order to clarify whether the
organelles double positive for VGLUT1-pHluorin and the
marker of early endosomes (EAA1) represent a population
different from SLMVs, we estimated the average fluorescence
profiles (radial sweep; [23]) of fluorescent vesicles from the
double immunofluorescent labeling experiments shown in
Figure 1(h). For analysis, we compared the half maximum
values (FWHM) of the curve obtained from isolated green
fluorescent dots representing VGLUT1-pHluorin which colo-
calize with EAA1 with the corresponding value of radial
sweep curves of fluorescent beads of different diameters
(40 nm and 200 nm). We found that the VGLUT1-pHluorin
dots colocalized with EAA1 had a FWHM value similar to
that of 200 nm beads (490 ± 5 nm, 𝑛 = 20; 506 ± 6 nm,
𝑛 = 20, resp., Figures 2(a) and 2(b)). Conversely, the green
fluorescent dots of VGLUT1-pHluorin that do not colocalize
with EAA1 had FWHM comparable to that of fluorescent
beads of 40 nm of diameter (349±7 nm and 361±6 nm, resp.,
𝑛 = 20 for each, Figures 2(c) and 2(d)). Thus, the organelles
double positive for pHluorin and EAA1 were clearly a
different population of organelles from those expressing
only VGLUT1-pHluorin and most probably represent part of
VGLUT1-pHluorin-positive organelles undergoing endoso-
mal/lysosomal recycling pathway. In a parallel set of exper-
iments, in order to rigorously determine whether popula-
tion of VGLUT1-pHluorin positive vesicles also positive for
marker of recycling endosomeswas able to undergo regulated
exocytosis, we monitored the exocytosis processes evoked
by an agonist of group I metabotropic glutamate receptors
(mGluR), dihydroxyphenylglycine (DHPG) [9, 29]. Primary
astrocytes transfected with VGLUT1-pHluorin and preincu-
bated with a specific marker of recycling endosomes (Alexa
568-conjugated transferrin, [35]) have been challenged with
DHPG (100 𝜇M) for 2 seconds (s). The VGLUT1-pHluorin-
and the Alexa568-positive vesicles have been followed in real
time with the dual wavelength TIRF experiments (488 nm
and 568 nm laser TIRF). Two seconds of DHPG application
evoked a burst of exocytosis of VGLUT1-pHluorin vesicles as
previously reported (Figure 2(e); [9]) and only 16% of fusion
events of VGLUT1-pHluorin/Alexa-568 double positive vesi-
cles (Figure 2(f)). Overall, these data showed that VGLUT1-
pHluorin can be used as a surrogatemarker for glutamatergic
SLMVs in astrocytes.
To analyze the role of prostaglandins (PGs) in theDHPG-
evoked exocytosis of glutamatergic vesicles in astrocytes,
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Figure 1: VGLUT1-pHluorin is mainly expressed on a specific population of glutamatergic synaptic like microvesicles. In the figure the
left panels (in green) show astrocytes transfected with VGLUT1-pHluorin construct revealed by rabbit antibody against GFP. The middle
panels (in red) show the markers of the intracellular secretory organelles, revealed by mouse antibodies against specific markers of ((a)–(e))
synaptic like microvesicles ((a) VGLUT1, (b) VGLUT2, (c) VAMP3, (d) glutamate, (e) VAMP2), of (f) dense core granules (phogrin), of (g)
late endosomes, multivesicular bodies and lysosomes (LAMP1), of (h) early endosomes (EAA1), and of (i) recycling endosomes (transferrin
receptor, Tfr). The right panels show the merged images. Bars: 20𝜇m.
we started by monitoring single exocytic events of VGLUT1-
pHluorin-associated vesicles (Figures 3(a) and 3(b); [9]),
evoked by two distinct protocols of receptor stimula-
tion. When either purinergic receptor or glutamatergic
receptor agonists were locally administrated (ATP, 100 𝜇M,
or coapplication of t-ACPD and AMPA each at 50 𝜇M),
rapid burst of exocytosis was elicited (Figures 3(c) and
3(e)), suggesting that the two stimulation protocols shared
similar excitation-secretion coupling mechanism.The nature
of the receptors activated by the three protocols of stimula-
tion was then investigated by pharmacological agents with
known selectivity. The response to ATP was abolished by
pretreatment with PPADS (−86%, 100 𝜇M), an agonist of
most P2 purinergic receptors, as well as with A3P5PS (−83%,
100 𝜇M), a selective P2Y
1
antagonist (Figure 3(d); [36]).
Consistent with these results, 2MeSADP, a P2Y
1
agonist,
potently stimulated glutamate exocytosis (data not shown),
(see Supplementary Figure 1; in Supplementary Material
available online at http://dx.doi.org/10.1155/2014/254574 [5,
17]), suggesting that P2Y
1
receptors are the predominant
mediators of the glutamate exocytosis action of ATP. The
presence of P2Y
1
receptors in astrocytes and their role in
Ca2+ signaling pathway leading to modulation of synaptic
activity have recently been reported [5, 37]. As for glutamate,
it has been established that the potent glutamate releasing
effect of t-ACPD+AMPA in astrocytesmainly depends on the
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Figure 2: Analysis of VGLUT1-pHluorin vesicles that colocalize with markers of early or recycling endosomes. (a)–(d) Estimation of the size
of vesicles expressing VGLUT1-pHluorin. Analysis of individual vesicle was performed in confocal images of VGLUT1-pHluorin-expressing
astrocytes by plotting fluorescence intensity of pHluorin spots against distance from the centre of the spot (black curve± SD). Such an analysis
provided an estimation of the average fluorescence profile otherwise called “radial sweep” [23]. The fluorescence intensity values obtained
from the radial sweep were well fitted by a one-dimensional Gaussian function (red curve). Such a curve represents the average radial sweep
value obtained from 20 vesicles. Note that the half maximum value of pHluorin-expressing vesicle positive for EAA1 ((b), marker of early
endosomes, 490 ± 5 nm) is similar to that of 200 nm fluorescent beads ((a), 506 ± 6 nm) and the half maximum value of pHluorin-expressing
vesicle that do not express EAA1 ((d), 349±7 nm) is similar to that of 40 nm fluorescent beads ((c), 361±6 nm). (e), (f) Temporal distribution
of VGLUT1-pHluorin and Alexa-Tf 568 fusion events evoked by DHPG application. (e) Each individual histogram represents the number
(mean ± SD) of fusion events detected from VGLUT1-pHluorin vesicles in a 50ms-long frame (𝑛 = 5 cells). (f) Fusion events (mean ± SD)
detected from VGLUT1-pHluorin and Alexa-Tf568 double positive vesicles in the same cells as in (e). Each histogram represents the number
of fusion events detected in a 50ms-long frame (𝑛 = 5 cells).
simultaneous activation of group I mGluRs and ionotropic
receptors of the AMPA-preferring subtype [2]. Here, we
confirm that the response to t-ACPD+AMPA (each at 50 𝜇M)
is reduced to less than 40% by administration of MCPG
(−78%, 500 𝜇M), a nonselective mGluR antagonist, and by
MPEP (−82%, 200 nM), a specific antagonist selective for
mGluR5 (Figure 3(f)). On the whole, pharmacological profile
identified mGluR5 as the metabotropic receptor subtype that
is implicated in the glutamate release response to glutamater-
gic stimulation. Consistent with these results, DHPG, an
agonist of the group I ofmGluR, evoked glutamate exocytosis
in astrocytes [9, 29]. The two receptors here identified as
mediators of the exocytosis of glutamatergic vesicles in
astrocytes belong to the G protein-coupled family, which are
known to be expressed in astrocytes and to release Ca2+ from
internal stores via IP3 pathway [38].
Glutamatergic stimulation of astrocytes is known to pro-
mote rapid, phospholipase A2-dependent activation of the
arachidonic acid cascade [2, 39]. Pharmacological inhibition
of the different eicosanoid-forming pathways indicates that
cyclooxygenase (COX) but not other arachidonate metabolic
enzymes is involved in the mechanism leading to glutamate
release [2, 15, 17]. COX is an enzyme that is responsible for
the formation of prostanoids [40]. The three main groups
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Figure 3: Pharmacological characterization of the receptor subtypes mediating exocytosis of VGLUT1-pHluorin positive vesicles in response
to ATP and glutamate agonists. (a) TIRF image showing an astrocyte transfected with VGLUT1-pHluorin. Bar 20 nm. (b) Stereotyped
sequence of pHluorin destaining reveals exocytosis of a VGLUT1-pHluorin positive vesicle. The sequential gray scale micrographs represent
the fate of pHluorin before (−100ms) and during (100, 200, 400ms) the fusion event. Bars: 380 nm. The scheme shows the behaviour of
pHluorin before and after fusion event. Note that the color code for the pHluorin fluorescence signal is gray when the signal is off and green
when it is on. (c), (d) P2Y
1
receptors mediate the ATP-evoked exocytosis. (c) Temporal distribution of fusion events evoked by ATP (100𝜇M).
(d) Histograms represent the total number of fusion events evoked by ATP (417.14 ± 32.4) that is strongly inhibited in the presence of the P2
purine antagonists PPADS (100𝜇M, 58.6 ± 7) as well as of the P2Y
1
-selective compound, A3P5PS (100𝜇M, 70.2 ± 5.8). Data are ± SEM of 4
cells. (e), (f) mGluR5mediates the response to t-ACPD, in the presence of AMPA. (e) Temporal distribution of fusion events evoked by 50 𝜇M
t-ACPD+50𝜇MAMPA. (f) Histograms represent the total number of fusion events evoked by t-ACPD+AMPA (447.1 ± 28.7) that is strongly
inhibited in the presence of themGluR antagonists, including the subtype-nonselectiveMCPG (500𝜇M, 98.3±7.4) and themGluR5-selective
MPEP (200 nM, 80.1 ± 7). Data are ± SEM of 4 cells. Statistical significance of inhibition with receptor antagonists was calculated using t-test
(∗∗𝑃 < 0.01).
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Figure 4: COX blockers strongly inhibit the exocytosis of glutamate evoked by activation of group I mGluR and of purinergic P2Y
1
receptor.
(a), (b) Quantitative histograms represent the total number of fusion events evoked by either DHPG (100𝜇M, 456.7 ± 54.8) or 2MeSADP
(20 𝜇M, 467.6 ± 46.8) in the presence of COX blockers, INDO (1𝜇M; 94.9 ± 9.6, 88.8 ± 5.4, resp.) or ASA (10 𝜇M, 86.4 ± 11.7, 79.5 ± 14.4,
resp.). Data are ± SEM of 4 cells. Statistical significance of inhibition with receptor antagonists was calculated using t-test (∗∗𝑃 < 0.01).
of prostanoids (prostaglandins, prostacyclins, and thrombox-
anes) are each involved in the inflammatory response but
prostaglandins (PGs) can control release of glutamate from
astrocytes. We studied the involvement of PGs in the DHPG-
evoked exocytosis of glutamatergic SLMVs by preincubating
cells with two COX inhibitors, indomethacin (INDO, 1𝜇M)
and aspirin (ASA, 10𝜇M). We found that the two anti-
inflammatory drugs decreased by about 80% the releasing
effect of DHPG and of 2MeSADP (Figures 4(a) and 4(b)).
This evidence is consistent with a scenario in which the
excitation-secretion pathway leading to glutamate exocytosis
from astrocytes is controlled, at some level, by the COX
pathway.
In light of the above results, we wanted to examine the
mechanism by which COX inhibitors decreased glutamate
exocytosis in astrocytes. It is well known that a COX product,
prostaglandin E
2
(PGE
2
), is formed and released in extracel-
lular space after activation of mGluRs [2] and that it causes
by itself intracellular Ca2+ elevations leading to glutamate
release in astrocytes [2, 14]. Interestingly, we also found that
the time course analysis of PGE
2
accumulation in response
to activation of glutamatergic or purinergic receptors was
almost maximal within the first 3 seconds of stimulation
(Figure 5(a); [2, 17]). Therefore, the kinetics of the PGE
2
release is fully compatible with a potential role of this COX
metabolite in rapid cell signaling. We wanted to investigate
the effect of PGE
2
on the intracellular pathways leading
to exocytic burst of glutamatergic SLMVs. We found that
administration of PGE
2
(50 𝜇M) to astrocytes caused a rapid
burst of exocytosis that did not depend on Ca2+ influx
from outside of the cells but on Ca2+ release from internal
store (Figure 5(b)). In fact incubation with cyclopiazonic
acid (1 𝜇M), which causes depletion of Ca2+ from internal
stores by blocking SERCA, abolished the response to PGE
2
(Figure 5(b) inset). Since PGE
2
is released upon receptor
activation and promotes per seCa2+ elevations and glutamate
release, we specifically investigated whether extracellular
PGE
2
contributes to the physiological response of astrocytes
to glutamate exocytosis. We blocked extracellular PGE
2
with
a specific antibody (AbPGE
2
). Figure 5(d) shows that when
AbPGE
2
was present in the bath, a condition in which PGE
2
is rapidly and efficiently sequestered (AbPGE
2
buffering
capacity is >1000 pg/mL PGE
2
), DHPG- evoked exocytosis of
glutamatergic SLMVs was significantly reduced (−43 ± 12%,
𝑛 = 6 cells). Similar results were obtained for 2MeSADP
(Supplementary Figure 1(b); −51 ± 14%, 𝑛 = 4 cells, resp.).
Interestingly, the action ofAbPGE
2
was specific and could not
be reproduced by the boiled protein (not shown). Therefore,
the whole body of evidence suggests that extracellular PGE
2
accounts for a significant component of mGluR5- and P2Y
1
-
dependent exocytosis of glutamatergic SLMVs in astrocytes.
4. Discussion
Astrocytes play an important role in the integration of rapid
chemical signaling in the brain [41]. They function as signal
integrators, since they generate outputs with variable timing
in response to particular signals received from surrounding
neuronal cells to communicate with the same neurons and/or
with other cellular components of the brain circuits. A
crucial element that facilitates the integrating functions of
astrocytes is the regulated exocytosis of chemical substances
[9, 29, 42–44]. By this process, astrocytes exert modulatory
influences on neighboring cells and are thought to participate
in the control of synaptic circuits and cerebral blood flow
[45, 46]. Exocytosis is an evolutionary trait of eukaryotic
cells that leads in a given secretory cell to a release of
chemical content by a fast mechanism into the extracellular
space and thus to communication with neighboring cells. In
neurons, exocytosis represents one of the fastest biological
events known. Similar to neurons or neurosecretory cells,
astrocytes express at least three different secretory organelles:
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Figure 5: Extracellular PGE
2
: accumulation in response to various stimuli and effects on exocytosis of glutamatergic vesicles. (a). Extracellular
accumulation of PGE
2
(expressed as pg/mL) in response to 3min stimulation with either t-ACPD+ AMPA (each at 50 𝜇M) or ATP (100 𝜇M).
Each point represents the average ± SEM of two experiments in triplicate with each stimulus. (b) Temporal distribution of fusion events
evoked by PGE
2
(50 𝜇M). Inset histograms represent the total number of fusion events evoked by PGE
2
(349 ± 26) in the presence of 0mM
Ca2+ and 5mM of EGTA (345±32) or cyclopiazonic acid (CPA, 10 𝜇M, 25±12). (c) Temporal distribution of fusion events evoked by DHPG
(100𝜇M). (d) Inhibitory effect of AbPGE
2
(buffering capacity >1000 pg/mL PGE
2
) on exocytosis of glutamatergic vesicles evoked by DHPG
(100𝜇M). Histograms represent temporal distribution of fusion events evoked by DHPG in the presence of AbPGE
2
. Statistical significance
was calculated using t-test (∗𝑃 < 0.05).
the small synaptic like microvesicles (SLMVs) [29, 30, 47],
the large dense core granules (LDCGs) [31, 32, 48] which
store and release distinct cargo, and lysosomes [49, 50]. In
neurons and specialized secretory cells, these organelles have
specialized physiological functions, are typically found in
different regions of the cell and are regulated by different
intracellular signaling pathways of calcium. Interestingly, in
our immunolabeling and confocal analysis performed in cul-
tured astrocytes we found that small VAMP3-, VGLUT1-, and
glutamate-positive SLMVs, large phogrin-positive DCGs,
and lysosomes positive for markers of multivesicular bodies
and late endosomes or early and recycling endosomes exist
in the same astrocytes. Our results confirmed that the task
of identifying a specific population of secretory organelles in
astrocytes is very difficult. Moreover, studying properties of
exocytosis constitutes a challenge because the cell biological
basis of this process is very incompletely defined in these
cells. For example, researchers have only recently started to
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understand that astrocytic exocytosis relies on multiple pop-
ulations of secretory vesicles, which calls for the definition
of adequate criteria to recognize the distinct populations
and study them in isolation. In fact, most of the early
studies of astrocyte exocytosis could not distinguish such
heterogeneity as they used generic exocytosis reporters (such
as synthetic fluorescent dyes). Thus, these studies did not
allow an accurate description of the dynamics and properties
of astrocytic secretion because they mixed contributions by
more than one exocytic organelle population. As a result,
the types of vesicles used in Ca2+-regulated exocytosis in
astrocytes are under debate. A good experimental strategy
involves trying to specifically live-stain a selected population
(e.g., by transfecting the cells with a population-specific fluo-
rescent reporter). This approach must, however, be validated
by subsequent co-localization analysis with markers of the
intracellular organelles, which will provide additional useful
information on the nature of the stained organelles. By com-
bining TIRF experiments and transfection of a fluorescent
tool used to visualize exo/endocytosis processes in living
neurons (VGLUT1-pHluorin) [28], we visualized VGLUT1-
positive SLMVs. We therefore characterized vesicles express-
ing VGLUT1 and found that they have diameter similar to
that of fluorescent beads of 40 nm, contain glutamate, and
express at least one of the VAMP proteins necessary for
regulated exocytosis (VAMP3).
Once confirmed that VGLUT1-pHluorin was a correct
tool for studying glutamatergic SLMVs in astrocytes, we
then investigated the activity of the two endogenous medi-
ators that participate in brain intercellular chemical com-
munication: glutamate and ATP. Glutamate and ATP are
well-recognized brain signaling agents that are released in
response to neuronal or glial cell stimulation and thatmediate
intercellular signaling [7, 51]. Independently of their origin,
both glutamate and ATP were previously shown to activate
astrocytes causing intracellular Ca2+ increase followed by
glutamate release [2, 52, 53]. The Ca2+-dependent exocy-
tosis of glutamate in astrocytes is controlled by multiples
mediators, all acting via receptors that belong to the GPCR
super family stimulating IP3 productions (P2Y
1
for ATP,
mGluR5 for glutamate). Stimulation of GPCR also promoted
stimulation of the COX pathway of the arachidonic acid
metabolism with the ensuing production and release of PGs
being critical for the full efficiency of the excitation-secretion
coupling in astrocytes. We in fact found that COX inhibition
caused a dramatic reduction in the total number of fusion
events of glutamatergic SLMVs caused by activation of both
purinergic and glutamatergic receptors. By analyzing the
temporal distribution of the exocytic events, we found an
intriguing aspect of the mode of action of PGs. Inhibition of
the PGs by either COX inhibitors or a neutralizing antibody
specific for PGE
2
produced a significant modification of the
temporal characteristics of the exocytic burst. In particular,
while the fast initial component (0–400ms) was most often
left intact, the second component of the burst (500ms–
1.6 s) was often suppressed or significantly slowed down,
suggesting that PG-mediated signaling is heavily implicated
in this later, slower phase of the release. Interestingly, the
rapid phase of the exocytic burst was sustained almost
exclusively by “resident” vesicles, whereas the slow phase was
mainly sustained by “newcomer” vesicles [9]. This duality
is reminiscent of observations previously done in neurons
where only readily releasable synaptic vesicles are rapidly
recycled and reused [54]. As we do not know whether the
“newcomer” and the “resident” vesicles represent distinct
population of SLMVs, it is possible that the “newcomers”
may indeed represent the same population of “resident”
vesicles that undergoes a second round of exocytosis upon
rapid recycling. In this context PGE
2
seemed to amplify the
second round of exocytosis. Since it is known that PGE
2
is immediately released from astrocytes upon stimulation
[2, 17] and that exogenous PGE
2
induced rapid, Ca2+-
dependent burst of glutamatergic SLMVs, it follows that a
component of the burst of exocytosis in response to glutamate
or ATP requires an autocrine/paracrine action of PGE
2
.
The comparison effects of the COX blockers (about −80%)
and AbPGE
2
(about −45%) also indicate that extracellular
PGE
2
cannot be solely responsible for all the observed COX-
dependent events. At present we do not have a specific
explanation for these differences. It is possible that other PGs
could be released together with PGE
2
. For instance, it has
been shown that intracellular Ca2+ elevations in astrocytes
are known to stimulate the production of a full range of
COX derivates [55] and some of them have been shown
to cause Ca2+ rises and glutamate release from astrocytes
[2, 56]. The present data confirm and extend our previous
finding that PGE
2
participates to glutamate-dependent cell-
cell communication [2], suggesting a physiological function
for this mediator in the intact brain. The autocrine/paracrine
action of PGE
2
may thus participate in the spatial control
of astrocytic signal propagation. Therefore, it is possible that
alterations in PGs synthesis during brain inflammations and
other pathological states have a profound impact on the
chemical communication in the brain. PGE
2
stimulation,
for instance, acts downstream of CXCL12, as well as TNF𝛼
pathways. Although both these pathways have been suggested
to be involved in the physiological glutamate-mediated brain
signalling [5, 26], it is likely that PGE
2
synthesis will be
largely amplified during inflammatory conditions, following
the fate of its upstream inflammatory messengers [18]. As
thewhole pathway increases glutamate release from astroglial
cells,muchhigher levels of PGE
2
might represent the ultimate
messenger leading to pathological increase of extracellular
glutamate levels.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Authors’ Contribution
Corrado Cali and Jan Lopatar contributed equally to this
work.
10 Neural Plasticity
Acknowledgments
This work was supported by a Grant from Novartis Founda-
tion (26077772) to P. Bezzi.The authors thank R. H. Edwards
and S. Voglmaier (UCSF, USA) for providing the pHluorin
construct; J. Marchaland, J. Gremion, and S. Menetrey for the
experimental support.
References
[1] L. Pasti, A. Volterra, T. Pozzan, and G. Carmignoto, “Intra-
cellular calcium oscillations in astrocytes: a highly plastic,
bidirectional form of communication between neurons and
astrocytes in situ,” The Journal of Neuroscience, vol. 17, no. 20,
pp. 7817–7830, 1997.
[2] P. Bezzi, G. Carmignoto, L. Pasti et al., “Prostaglandins stimulate
calcium-dependent glutamate release in astrocytes,”Nature, vol.
391, no. 6664, pp. 281–285, 1998.
[3] A. Araque, E. D. Mart´ın, G. Perea, J. I. Arellano, and W. Bun˜o,
“Synaptically released acetylcholine evokes Ca2+ elevations in
astrocytes in hippocampal slices,” The Journal of Neuroscience,
vol. 22, no. 7, pp. 2443–2450, 2002.
[4] G. Perea and A. Araque, “Properties of synaptically evoked
astrocyte calcium signal reveal synaptic information processing
by astrocytes,” The Journal of Neuroscience, vol. 25, no. 9, pp.
2192–2203, 2005.
[5] M. Santello, P. Bezzi, and A. Volterra, “TNF𝛼 controls gluta-
matergic gliotransmission in the hippocampal dentate gyrus,”
Neuron, vol. 69, no. 5, pp. 988–1001, 2011.
[6] A. Verkhratsky, R. K. Orkand, and H. Kettenmann, “Glial calci-
um: homeostasis and signaling function,” Physiological Reviews,
vol. 78, no. 1, pp. 99–141, 1998.
[7] P. Bezzi and A. Volterra, “A neuron-glia signalling network in
the active brain,” Current Opinion in Neurobiology, vol. 11, no. 3,
pp. 387–394, 2001.
[8] A. Volterra and J. Meldolesi, “Astrocytes, from brain glue to
communication elements: the revolution continues,” Nature
Reviews Neuroscience, vol. 6, no. 8, pp. 626–640, 2005.
[9] J. Marchaland, C. Cal`ı, S. M. Voglmaier et al., “Fast subplasma
membrane Ca2+ transients control exo-endocytosis of synaptic-
like microvesicles in astrocytes,” The Journal of Neuroscience,
vol. 28, no. 37, pp. 9122–9132, 2008.
[10] M. T.Martineau Shi, J. Puyal, A.M. Knolhoff et al., “Storage and
uptake of D-serine into astrocytic synaptic-like vesicles specify
gliotransmission,” The Journal of Neuroscience, vol. 33, no. 8,
article U3605, pp. 3413–3423, 2013.
[11] T. Liu, L. Sun, Y. F. Xiong et al., “Calcium triggers exocytosis
from two types of organelles in a single astrocyte,” The Journal
of Neuroscience, vol. 31, no. 29, pp. 10593–10601, 2011.
[12] C. Verderio and M. Matteoli, “ATP in neuron-glia bidirectional
signalling,” Brain Research Reviews, vol. 66, no. 1-2, pp. 106–114,
2011.
[13] M. Oya, T. Kitaguchi, Y. Yanagihara et al., “Vesicular nucleotide
transporter is involved in ATP storage of secretory lysosomes in
astrocytes,” Biochemical and Biophysical Research Communica-
tions, vol. 438, no. 1, pp. 145–151, 2013.
[14] Sanzgiri, R. P. A. Araque, and P. G. Haydon, “Prostaglandin E2
stimulates glutamate receptor-dependent astrocyte neuromod-
ulation in cultured hippocampal cells,” Journal of Neurobiology,
vol. 41, no. 2, pp. 221–229, 1999.
[15] P. Bezzi, M. Domercq, L. Brambilla et al., “CXCR4-activated
astrocyte glutamate release via TNFa: amplification by
microglia triggers neurotoxicity,” Nature Neuroscience, vol. 4,
no. 7, pp. 702–710, 2001.
[16] D. Rossi, L. Brambilla, C. F. Valori et al., “Defective tumor
necrosis factor-𝛼-dependent control of astrocyte glutamate
release in a transgenic mouse model of Alzheimer disease,”The
Journal of Biological Chemistry, vol. 280, no. 51, pp. 42088–
42096, 2005.
[17] M. Domercq, L. Brambilla, E. Pilati, J. Marchaland, A. Volterra,
and P. Bezzi, “P2Y1 receptor-evoked glutamate exocytosis from
astrocytes—control by tumor necrosis factor-𝛼 and prostagl-
andins,”The Journal of Biological Chemistry, vol. 281, no. 41, pp.
30684–30696, 2006.
[18] D. Rossi, F. Martorana, and L. Brambilla, “Implications of glio-
transmission for the pharmacotherapy of CNS disorders,” CNS
Drugs, vol. 25, no. 8, pp. 641–658, 2011.
[19] D. Stellwagen and R. C.Malenka, “Synaptic scalingmediated by
glial TNF-𝛼,” Nature, vol. 440, no. 7087, pp. 1054–1059, 2006.
[20] G. G. Turrigiano, “The self-tuning neuron: synaptic scaling of
excitatory synapses,” Cell, vol. 135, no. 3, pp. 422–435, 2008.
[21] E. C. Beattie, D. Stellwagen, W. Morishita et al., “Control of
synaptic strength by glial TNF𝛼,” Science, vol. 295, no. 5563, pp.
2282–2285, 2002.
[22] D. Stellwagen, E. C. Beattie, J. Y. Seo, and R. C. Malenka,
“Differential regulation of AMPA receptor and GABA receptor
trafficking by tumor necrosis factor-𝛼,” The Journal of Neuro-
science, vol. 25, no. 12, pp. 3219–3228, 2005.
[23] D. Zenisek, J. A. Steyer, M. E. Feldman, and W. Almers, “A
membrane marker leaves synaptic vesicles in milliseconds after
exocytosis in retinal bipolar cells,” Neuron, vol. 35, no. 6, pp.
1085–1097, 2002.
[24] S. M. Voglmaier, K. Kam, H. Yang et al., “Distinct endocytic
pathways control the rate and extent of synaptic vesicle protein
recycling,” Neuron, vol. 51, no. 1, pp. 71–84, 2006.
[25] S. Chevlet, P. Bezzi, R. Ivarsson et al., “Tomosyn-1 is involved in
a post-docking event required for pancreatic 𝛽-cell exocytosis,”
Journal of Cell Science, vol. 119, no. 14, pp. 2912–2920, 2006.
[26] C. Cal`ı, J. Marchaland, R. Regazzi, and P. Bezzi, “SDF 1-alpha
(CXCL12) triggers glutamate exocytosis from astrocytes on a
millisecond time scale: imaging analysis at the single-vesicle
level with TIRF microscopy,” Journal of Neuroimmunology, vol.
198, no. 1-2, pp. 82–91, 2008.
[27] A. Bergeron, P. Bezzi, and R. Regazzi, “Analysis of synaptic-
like microvesicle exocytosis of beta-cells using a life imaging
technique,” PloS ONE. In press.
[28] S. M. Voglmaier and R. H. Edwards, “Do different endocytic
pathways make different synaptic vesicles?” Current Opinion in
Neurobiology, vol. 17, no. 3, pp. 374–380, 2007.
[29] P. Bezzi, V. Gundersen, J. L. Galbete et al., “Astrocytes contain a
vesicular compartment that is competent for regulated exocyto-
sis of glutamate,”Nature Neuroscience, vol. 7, no. 6, pp. 613–620,
2004.
[30] L.H. Bergersen andV.Gundersen, “Morphological evidence for
vesicular glutamate release from astrocytes,” Neuroscience, vol.
158, no. 1, pp. 260–265, 2009.
[31] S. Coco, F. Calegari, E. Pravettoni et al., “Storage and release
of ATP from astrocytes in culture,” The Journal of Biological
Chemistry, vol. 278, no. 2, pp. 1354–1362, 2003.
[32] I. Prada, J. Marchaland, P. Podini et al., “REST/NRSF governs
the expression of dense-core vesicle gliosecretion in astrocytes,”
The Journal of Cell Biology, vol. 193, no. 3, pp. 537–549, 2011.
Neural Plasticity 11
[33] P. Bezzi and A. Volterra, “Monitoring exocytosis in astrocytes
with total internal reflection fluorescence microscopy,” in Opti-
cal Imaging Neurons: A LaboratoryManual, Cold SpringHarbor
Laboratory Press, Cold Spring Harbor, NY, USA, 2011.
[34] B. Borgonovo, E. Cocucci, G. Racchetti, P. Podini, A. Bachi, and
J. Meldolesi, “Regulated exocytosis: a novel, widely expressed
system,” Nature Cell Biology, vol. 4, no. 12, pp. 955–962, 2002.
[35] M. Park, J. M. Salgado, L. Ostroff et al., “Plasticity-induced
growth of dendritic spines by exocytic trafficking from recycling
endosomes,” Neuron, vol. 52, no. 5, pp. 817–830, 2006.
[36] V. Ralevic and G. Burnstock, “Receptors for purines and
pyrimidines,” Pharmacological Reviews, vol. 50, no. 3, pp. 413–
492, 1998.
[37] S. R. Fam, C. J. Gallagher, andM.W. Salter, “P2Y1 purinoceptor-
mediated Ca2+ signaling and Ca2+ wave propagation in dorsal
spinal cord astrocytes,”The Journal of Neuroscience, vol. 20, no.
8, pp. 2800–2808, 2000.
[38] A. Verkhratsky, “Calcium signalling between neurones and
glia,” European Journal of Neuroscience, vol. 10, pp. 322–322,
1998.
[39] N. Stella, M. Tence´, J. Glowinski, and J. Pre´mont, “Glutamate-
evoked release of arachidonic acid from mouse brain astro-
cytes,” The Journal of Neuroscience, vol. 14, no. 2, pp. 568–575,
1994.
[40] W. L. Smith and L. J. Marnett, “Prostaglandin endoperoxide
synthase: structure and catalysis,”Biochimica et Biophysica Acta,
vol. 1083, no. 1, pp. 1–17, 1991.
[41] V. Parpura, B. J. Baker, M. Jeras, and R. Zorec, “Regulated
exocytosis in astrocytic signal integration,” Neurochemistry
International, vol. 57, no. 4, pp. 451–459, 2010.
[42] Q. Zhang, M. Fukuda, E. Van Bockstaele, O. Pascual, and P. G.
Haydon, “Synaptotagmin IV regulates glial glutamate release,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 101, no. 25, pp. 9441–9446, 2004.
[43] D. Crippa, U. Schenk, M. Francolini et al., “Synaptobrevin2-
expressing vesicles in rat astrocytes: insights into molecular
characterization, dynamics and exocytosis,” The Journal of
Physiology, vol. 570, no. 3, pp. 567–582, 2006.
[44] T. Pangrsˇicˇ, M. Potokar, M. Stenovec et al., “Exocytotic release
of ATP from cultured astrocytes,” The Journal of Biological
Chemistry, vol. 282, no. 39, pp. 28749–28758, 2007.
[45] C. M. Anderson and M. Nedergaard, “Astrocyte-mediated
control of cerebral microcirculation,” Trends in Neurosciences,
vol. 26, no. 7, pp. 340–344, 2003.
[46] P. G. Haydon and G. Carmignoto, “Astrocyte control of synap-
tic transmission and neurovascular coupling,” Physiological
Reviews, vol. 86, no. 3, pp. 1009–1031, 2006.
[47] P. Jourdain, L. H. Bergersen, K. Bhaukaurally et al., “Glutamate
exocytosis from astrocytes controls synaptic strength,” Nature
Neuroscience, vol. 10, no. 3, pp. 331–339, 2007.
[48] P. Ramamoorthy and M. D. Whim, “Trafficking and fusion of
neuropeptide Y-containing dense-core granules in astrocytes,”
The Journal of Neuroscience, vol. 28, no. 51, pp. 13815–13827,
2008.
[49] J. K. Jaiswal, M. Fix, T. Takano, M. Nedergaard, and S. M.
Simon, “Resolving vesicle fusion from lysis tomonitor calcium-
triggered lysosomal exocytosis in astrocytes,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 104, no. 35, pp. 14151–14156, 2007.
[50] Z. J. Zhang, G. Chen, W. Zhou et al., “Regulated ATP release
from astrocytes through lysosome exocytosis,” Nature Cell
Biology, vol. 9, no. 8, article U115, pp. 945–953, 2007.
[51] R. D. Fields and B. Stevens, “ATP: an extracellular signaling
molecule between neurons and glia,” Trends in Neurosciences,
vol. 23, no. 12, pp. 625–633, 2000.
[52] M. L. Cotrina, J. H.-C. Lin, A. Alves-Rodrigues et al., “Con-
nexins regulate calcium signaling by controlling ATP release,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 95, no. 26, pp. 15735–15740, 1998.
[53] J. Xu, H. Peng, N. Kang et al., “Glutamate-induced exocytosis of
glutamate from astrocytes,”The Journal of Biological Chemistry,
vol. 282, no. 33, pp. 24185–24197, 2007.
[54] N. C. Harata, A. M. Aravanis, and R. W. Tsien, “Kiss-and-
run and full-collapse fusion as modes of exo-endocytosis in
neurosecretion,” Journal of Neurochemistry, vol. 97, no. 6, pp.
1546–1570, 2006.
[55] K. Oomagari, B. Buisson, A. Dumuis, J. Bockaert, and J.-P.
Pin, “Effect of glutamate and ionomycin on the release of
arachidonic acid, prostaglandins and HETEs from cultured
neurons and astrocytes,” European Journal of Neuroscience, vol.
3, no. 10, pp. 928–939, 1991.
[56] J. Kitanaka, K. Takuma, K. Kondo, and A. Baba, “Prostanoid
receptor-mediated calcium signaling in cultured rat astrocytes,”
Japanese Journal of Pharmacology, vol. 71, no. 1, pp. 85–87, 1996.
Submit your manuscripts at
http://www.hindawi.com
Neurology 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Alzheimer’s Disease
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Scientifica
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
Schizophrenia
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Neural Plasticity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
Autism
Sleep Disorders
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Neuroscience 
Journal
Epilepsy Research 
and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Psychiatry 
Journal
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Depression Research 
and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Brain Science
International Journal of
Stroke
Research and Treatment
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Neurodegenerative 
Diseases
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Cardiovascular Psychiatry 
and Neurology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
